Immunological characterization of reverse transcriptase from human tumor tissues.
D000818:Animals; D002415:Cats; D002648:Child; D003429:Cross Reactions; D005260:Female; D006801:Humans; D007106:Immune Sera / Q000494:pharmacology; D007938:Leukemia / Q000201:enzymology* / Q000276:immunology; D007951:Leukemia, Myeloid / Q000201:enzymology / Q000276:immunology; D015470:Leukemia, Myeloid, Acute / Q000201:enzymology / Q000276:immunology; D008223:Lymphoma / Q000201:enzymology* / Q000276:immunology; D008545:Melanoma / Q000201:enzymology / Q000209:etiology / Q000276:immunology; D009918:Orbital Neoplasms / Q000201:enzymology / Q000276:immunology; D012516:Osteosarcoma / Q000201:enzymology / Q000276:immunology; D010920:Placenta / Q000201:enzymology; D011247:Pregnancy; D055728:Primary Myelofibrosis / Q000201:enzymology; D012194:RNA-Directed DNA Polymerase / Q000276:immunology*; D012192:Retroviridae Infections / Q000201:enzymology / Q000276:immunology; D005253:Sarcoma Viruses, Feline / Q000276:immunology; D014412:Tumor Virus Infections / Q000150:complications
D007106:Immune Sera; D012194:RNA-Directed DNA Polymerase